The DOI matches its Crossref record; 612 of the 615 references it cites were found in a registry or an index.
Cardiac fibrosis
Open accessAbstract
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as transforming growth factor-β and platelet-derived growth factors), cytokines [including tumour necrosis factor-α, interleukin (IL)-1, IL-6, IL-10, and IL-4], and neurohumoral pathways trigger fibrogenic signalling cascades through binding to surface receptors, and activation of downstream signalling cascades. In addition, matricellular macromolecules are deposited in the remodelling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction, genetic cardiomyopathies, and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodelling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction1,2.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [2]
In the citing paper
“Among stromal cell types, fibroblasts are of particular interest given their role in tissue fibrosis, arrhythmias, and heart failure 16,29,30 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [30]
Citations
Cites
Items 401–600 of 612
Roh, J. D., Houstis, N. E., Yu, A., Chang, B. J., Yeri, A., Li, H., Hobson, R., Lerchenmüller, C., Vujić, A., Chaudhari, V., et al. (2020) · Aging Cell · doi:10.1111/acel.13159 · Cited by 97
Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology
Nagueh, S. F. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa228 · Cited by 97
Yan, W., Wang, P., Zhao, C. X., Tang, J., Xiao, X., & Wang, D. W. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.204 · Cited by 96
Liu, J., Zhuang, T., Pi, J., Chen, X., Zhang, Q., Li, Y., Wang, H., Shen, Y., Tomlinson, B., Chan, P., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039767 · Cited by 95
Aelst, L. N. L. V., Voss, S., Carai, P., van Leeuwen, R. E. W., Vanhoutte, D., Wijk, S. S., Eurlings, L. W. M., Swinnen, M., Verheyen, F., Verbeken, E. V., et al. (2014) · Circulation Research · doi:10.1161/circresaha.116.304599 · Cited by 94
Sriramula, S., & Francis, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138372 · Cited by 94
Lauriol, J., Keith, K., Jaffré, F., Couvillon, A. D., Saci, A., Goonasekera, S. A., McCarthy, J. R., Kessinger, C. W., Wang, J., Ke, Q., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005262 · Cited by 93
The Mechanical Environment Modulates Intracellular Calcium Oscillation Activities of Myofibroblasts
Godbout, C., Castella, L. F., Smith, E. A., Talele, N. P., Chow, M. L., Garonna, A., & Hinz, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064560 · Cited by 93
Xu, J., Lin, S.-C., Chen, J., Miao, Y., Taffet, G. E., Entman, M. L., & Wang, Y. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01114.2010 · Cited by 93
Herum, K. M., Lunde, I. G., Skrbic, B., Louch, W. E., Hasic, A., Boye, S., Unger, A., Brorson, S.-H., Sjaastad, I., Tønnessen, T., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv002 · Cited by 92
Lijnen, P. J., Papparella, I., Petrov, V. V., Semplicini, A., & Fagard, R. H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217860.04994.54 · Cited by 92
Galectin-3 and heart failure: Prognosis, prediction & clinical utility
Filipe, M. D., Meijers, W. C., van der Velde, A. R., & de Boer, R. A. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.009 · Cited by 92
Wollert, K. C., Studer, R., Doerfer, K., Schieffer, E., Holubarsch, C., Just, H., & Drexler, H. (1997) · Circulation · doi:10.1161/01.cir.95.7.1910 · Cited by 92
A pro-fibrotic role for interleukin-4 in cardiac pressure overload
Kanellakis, P., Ditiatkovski, M., Kostolias, G., & Bobik, A. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs142 · Cited by 92 · cited 1×
“Moreover, in a model of pressure overload induced through TAC, IL-4 neutralization attenuated fibrotic changes.(199) IL-4 may exert direct fibrogenic actions by stimulating collagen synthesis in cardiac fibroblasts through activation of STAT6.”
BackgroundBuckley, L. F., Canada, J. M., Buono, M. G. D., Carbone, S., Trankle, C. R., Billingsley, H., Kadariya, D., Arena, R. A., Tassell, B. W. V., & Abbate, A. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12235 · Cited by 92
Evidence for an Active Inflammatory Process in the Hibernating Human Myocardium
Frangogiannis, N. G., Shimoni, S., Chang, S. M., Ren, G., Shan, K., Aggeli, C., Reardon, M. J., Letsou, G. V., Espada, R., Ramchandani, M. K., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62568-0 · Cited by 91 · cited 1×
“In human patients with ischaemic cardiomyopathy undergoing aortocoronary bypass surgery, highly cellular interstitial fibrosis, characterized by increased inflammatory activity, and higher levels of the matricellular protein tenascin-C was associated with more dynamic lesions and with an increased likelihood of recove…”
BackgroundSelf-citationKrishnamurthy, P., Lambers, E., Verma, S. K., Thorne, T. E., Qin, G., Losordo, D. W., & Kishore, R. (2010) · The FASEB Journal · doi:10.1096/fj.09-149815 · Cited by 91 · cited 1×
“In a model of non-reperfused MI, IL-10 was found to inhibit fibrosis.(208) Moreover, in a model of pressure overload, endogenous IL-10 derived from haematopoietic cells inhibited fibrosis, through actions attributed to attenuated maturation of fibroblast progenitors.”
BackgroundNoh, H., Yu, M. R., Kim, H. J., Lee, J. H., Park, B., Wu, I., Matsumoto, M., & King, G. L. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.013 · Cited by 90
Cardiac myocyte–secreted cAMP exerts paracrine action via adenosine receptor activation
Sassi, Y., Ahles, A., Truong, D. J., Baqi, Y., Lee, S.-Y., Husse, B., Hulot, J., Foinquinos, A., Thum, T., Müller, C. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74349 · Cited by 88
MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes
Sakai, N., Wada, T., Furuichi, K., Shimizu, K., Kokubo, S., Hara, A., Yamahana, J., Okumura, T., Matsushima, K., Yokoyama, H., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0305127 · Cited by 87 · cited 1×
“of monocytes and macrophages expressing the main CCL2 receptor, CCR2, resulting in up-regulation of fibrogenic mediators, such as TGF-b and osteopontin.(128,129,137) Although CCL2 has been suggested to pro-”
BackgroundVillar, A. V., García, R., Llano, M., Cobo, M., Merino, D., Lantero, A., Tramullas, M., Hurlé, J. M., Hurlé, M. A., & Nistal, J. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.007 · Cited by 86
Regulation of the Structural Remodelling of the Myocardium: from Hypertrophy to Heart Failure
Brilla, C. G., & Maisch, B. (1994) · European Heart Journal · doi:10.1093/eurheartj/15.suppl_d.45 · Cited by 86
Yamamoto, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00101-2 · Cited by 86
Salvarani, N., Maguy, A., Simone, S. A. D., Miragoli, M., Jousset, F., & Rohr, S. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004567 · Cited by 86
IL‐11 in cardiac and renal fibrosis: Late to the party but a central player
Corden, B., Adami, E., Sweeney, M. D., Schäfer, S., & Cook, S. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15013 · Cited by 86 · cited 1×
“The gp130 cytokine IL-11 has also been suggested to act as a critical downstream signal mediating TGF-b-driven fibrosis not only in the heart(187) but also in other organs.(188,189)”
BackgroundPlatelet-derived growth factor receptor-α is essential for cardiac fibroblast survival
Ivey, M. J., Kuwabara, J. T., Riggsbee, K. L., & Tallquist, M. D. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00054.2019 · Cited by 85 · cited 1×
“signalling was found to be important for fibroblast survival and optimal support of the normal microvascular network.(20) However, these actions had no significant effects on baseline organ function.”
BackgroundSPARC mediates early extracellular matrix remodeling following myocardial infarction
McCurdy, S. M., Dai, Q., Zhang, J., Zamilpa, R., Ramirez, T. A., Dayah, T. J., Nguyen, N., Jin, Y.-F., Bradshaw, A. D., & Lindsey, M. L. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01070.2010 · Cited by 84
Verma, S. K., Garikipati, V. N. S., Krishnamurthy, P., Schumacher, S. M., Grisanti, L. A., Cimini, M., Cheng, Z. A., Khan, M., Yue, Y., Benedict, C., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027889 · Cited by 84
Targeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACs
Schuetze, K. B., McKinsey, T. A., & Long, C. S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.015 · Cited by 83
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling
Zymek, P., Nah, D.-Y., Bujak, M., Ren, G., Koerting, A., Leucker, T. M., Huebener, P., Taffet, G. E., Entman, M. L., & Frangogiannis, N. G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.028 · Cited by 83 · cited 1×
“significant effects on scar formation, myofibroblast infiltration and adverse remodelling.(207) In a model of non-reperfused MI, IL-10 was found to inhibit fibrosis.”
BackgroundSelf-citationJorgenson, A. J., Choi, K. M., Sicard, D., Smith, K. M. J., Hiemer, S. E., Varelas, X., & Tschumperlin, D. J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00205.2016 · Cited by 83
The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction
Abraham, D., Lee, T. E., Watson, L. J., Mao, L., Chandok, G., Wang, H., Frangakis, S. G., Pitt, G. S., Shah, S. H., Wolf, M. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95945 · Cited by 83
Bageghni, S. A., Hemmings, K. E., Yuldasheva, N. Y., Maqbool, A., Gamboa-Esteves, F. O., Humphreys, N. E., Jackson, M. S., Denton, C. P., Francis, S., Porter, K. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125074 · Cited by 83 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialSchimmel, K., Jung, M., Foinquinos, A., José, G. S., Beaumont, J., Bock, K., Grote-Levi, L. M., Xiao, K., Bär, C., Pfanne, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.042559 · Cited by 83
Accornero, F., van Berlo, J. H., Correll, R. N., Elrod, J. W., Sargent, M. A., York, A. J., Rabinowitz, J. E., Leask, A., & Molkentin, J. D. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00199-15 · Cited by 82 · cited 8×
“The fibrogenic effects of TNF-a, IL-1, and IL-6 may involve direct actions on fibroblasts, or indirect effects, related to recruitment of macrophages, induction of matricellular proteins and up-regulation of growth factors with prominent fibroblast-activating properties, such as TGF-b.”
BackgroundInfluentialFibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction
Shimizu, T., Narang, N., Chen, P., Yu, B., Knapp, M., Janardanan, J., Blair, J. E., & Liao, J. K. (2017) · JCI Insight · doi:10.1172/jci.insight.93187 · Cited by 82
Hermida, N., Michel, L. Y. M., Esfahani, H., Dubois‐Deruy, E., Hammond, J., Bouzin, C., Markl, A., Colin, H., Steenbergen, A. V., de Meester, C., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx366 · Cited by 81 · cited 2×
“Moreover, b2-AR signalling in myofibroblasts has been reported to exert pro-hypertrophic actions through paracrine mechanisms.118 Although the role of b3-AR signalling in fibroblasts is unknown, recent evidence suggests that cardiomyocyte-specific b3-AR signalling may exert anti-fibrotic actions by downmodulating expr…”
BackgroundHuang, S., Chen, B., Su, Y., Alex, L., Humeres, C. D., Shinde, A. V., Conway, S. J., & Frangogiannis, N. G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.006 · Cited by 81 · cited 1×
“In contrast, Smad2 does not seem to play a major role in mediating fibroblast activation in fibrotic hearts.(238) The contrasting effects of Smad2 and Figure 4 Regulation of TGF-b signalling in cardiac fibrosis.”
BackgroundSelf-citationVoloshenyuk, T. G., Hart, A. D., Khoutorova, E., & Gardner, J. D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.109 · Cited by 80
Lim, B., Choe, S.-C., Shin, J.-O., Ho, S., Kim, J., Yu, S., Kim, S., & Jeon, E. (2002) · Circulation · doi:10.1161/circ.105.11.1278 · Cited by 79
Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy
Weng, X., Yu, L., Peng, L., Chen, D., Cheng, X. F., Yang, Y., Li, L., Zhang, T., Zhou, B., Wu, X., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.009 · Cited by 79
Sam, F. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.10.007 · Cited by 79
Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy
Huang, Z.-P., Ding, Y., Chen, J., Wu, G., Kataoka, M., Hu, Y., Yang, J.-H., Liu, J., Drakos, S. G., Selzman, C. H., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw201 · Cited by 79
Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure
Hanif, W., Alex, L., Su, Y., Shinde, A. V., Russo, I., Li, N., & Frangogiannis, N. G. (2017) · Cardiovascular Pathology · doi:10.1016/j.carpath.2017.06.003 · Cited by 78
Self-citationWnt5a is elevated in heart failure and affects cardiac fibroblast function
Abraityte, A., Vinge, L. E., Askevold, E. T., Lekva, T., Michelsen, A. E., Ranheim, T., Alfsnes, K., Fiane, A. E., Aakhus, S., Lunde, I. G., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1529-1 · Cited by 77 · cited 1×
“In vitro, Wnt family members promote conversion of cardiac fibroblasts to myofibroblasts and stimulate cytokine synthesis.(264,265) In vivo, administration of a small molecule inhibitor that disables Porcn, thus preventing secretion of Wnt proteins, reduced fibrosis in a model of MI.”
BackgroundBET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice
Auguste, G., Rouhi, L., Matkovich, S. J., Coarfa, C., Robertson, M. J., Czernuszewicz, G., Gurha, P., & Marian, A. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135922 · Cited by 77
Zhang, J., Fan, G., Zhao, H., Wang, Z., Li, F., Zhang, P., Zhang, J., Wang, X., & Wang, W. (2017) · Scientific Reports · doi:10.1038/srep43146 · Cited by 76
Conventional Dendritic Cells Impair Recovery after Myocardial Infarction
Lee, J. S., Jeong, S., Kim, S., Chalifour, L. E., Yun, T. J., Miah, M. A., Li, B., Majdoubi, A., Sabourin, A., Keler, T., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800322 · Cited by 76
Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist
Moon, J., Zhou, H., Zhang, L.-S., Tan, W. H., Liu, Y., Zhang, S., Morlock, L., Bao, X., Palecek, S. P., Feng, J. Q., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621346114 · Cited by 75 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialDNA methylation regulated gene expression in organ fibrosis
Zhang, X., Hu, M., Lyu, X., Li, C., Thannickal, V. J., & Sanders, Y. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.010 · Cited by 75
Infarct Fibroblasts Do Not Derive from Bone Marrow Lineages
Moore-Morris, T., Cattaneo, P., Guimarães-Camboa, N., Bogomolovas, J., Cedenilla, M., Banerjee, I., Ricote, M., Kisseleva, T., Zhang, L., Gu, Y.-S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311490 · Cited by 75
Andenæs, K., Lunde, I. G., Mohammadzadeh, N., Dahl, C. P., Aronsen, J. M., Strand, M. E., Palmero, S., Sjaastad, I., Christensen, G., Engebretsen, K. V. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201422 · Cited by 75
Alteration of Cardiac Collagen Phenotypes in Hypertensive Hypertrophy: Role of Blood Pressure
Mukherjee, D., & Sen, S. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1021 · Cited by 74
Urbina, P., & Singla, D. K. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2014 · Cited by 74 · cited 1×
“collagen deposition in models of pressure overload and diabetic cardiomyopathy.(22,245,246) The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.”
BackgroundSaxena, A., Bujak, M., Frunza, O., Dobaczewski, M. P., González-Quesada, C. J., Lu, B., Gerard, C. J., & Frangogiannis, N. G. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu138 · Cited by 74 · cited 2×
“In vitro, CXCL10 was found to inhibit growth-factor-mediated fibroblast migration,(69) through interactions with proteoglycans that were independent of the main CXCL10 receptor, CXCR3.(150)”
BackgroundSelf-citationDahiya, S., Givvimani, S., Bhatnagar, S., Qipshidze, N., Tyagi, S. C., & Kumar, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101342 · Cited by 74
Integrin β 1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by Fibroblasts
Leask, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0365 · Cited by 74
Electrical coupling between ventricular myocytes and myofibroblasts in the infarcted mouse heart
Rubart, M., Tao, W., Lu, X., Conway, S. J., Reuter, S. P., Lin, S., & Soonpaa, M. H. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx163 · Cited by 74
Lee, J. K. T., Franzone, A., Lanz, J., Siontis, G. C. M., Stortecky, S., Gräni, C., Roost, E., Windecker, S., & Pilgrim, T. (2018) · Circulation · doi:10.1161/circulationaha.117.029858 · Cited by 74
Kato, S., Saito, N., Kirigaya, H., Gyotoku, D., Iinuma, N., Kusakawa, Y., Iguchi, K., Nakachi, T., Fukui, K., Futaki, M., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.048 · Cited by 72
Endothelin-1 upregulation mediates aging-related cardiac fibrosis
Wang, X., Guo, Z., Ding, Z., Khaidakov, M., Lin, J., Xu, Z., Sharma, S. G., Jiwani, S. S., & Mehta, J. L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.001 · Cited by 72
Syndecan-1 Amplifies Angiotensin II–Induced Cardiac Fibrosis
Schellings, M. W. M., Vanhoutte, D., van Almen, G. C., Swinnen, M., Leenders, J. J., Kubben, N., van Leeuwen, R. E. W., Hofstra, L., Heymans, S. R. B., & Pinto, Y. M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.137885 · Cited by 72
Ferreira, R. R., Abreu, R. D. S., Vilar-Pereira, G., Degrave, W., Meuser-Batista, M., Ferreira, N. V. C., Moreira, O. C., Gomes, N. L. D. S., de Souza, E. M., Ramos, I. P., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007602 · Cited by 72 · cited 1×
“Third, pharmacologic TGF-b inhibition strategies attenuated fibrosis in a model of pressure overload,(228) and in the fibrotic cardiomyopathy due to Chagas’ disease.(229) TGF-b exerts a broad range of direct effects on fibroblasts that may contribute to the pathogenesis of fibrosis.”
BackgroundDeterminants of coronary reserve in rats subjected to coronary artery ligation or aortic banding
Kalkman, E. A. J., Bilgin, Y. M., van Haren, P., van Suylen, R. J., Saxena, P. R., & Schoemaker, R. G. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00166-6 · Cited by 71
Komatsubara, I., Murakami, T., Kusachi, S., Nakamura, K., Hirohata, S., Hayashi, J., Takemoto, S., Suezawa, C., Ninomiya, Y., & Shiratori, Y. (2003) · Cardiovascular Pathology · doi:10.1016/s1054-8807(03)00042-5 · Cited by 71
McLellan, A. J. A., Ellims, A., Prabhu, S., Voskoboinik, A., Iles, L., Hare, J., Kaye, D. M., Macciocca, I., Mariani, J. A., Kalman, J. M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12948 · Cited by 71
Androulakis, A. F. A., Zeppenfeld, K., Paiman, E. H. M., Piers, S. R. D., Wijnmaalen, A. P., Siebelink, H. J., Šramko, M., Lamb, H. J., van der Geest, R. J., Riva, M., et al. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.12.005 · Cited by 71
Calcium Homeostasis and Ionic Mechanisms in Pulmonary Fibroblasts
Janssen, L. J., Mukherjee, S., & Ask, K. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0269tr · Cited by 70
Epigenetic regulation of cardiac fibrosis
Stratton, M. S., & McKinsey, T. A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.011 · Cited by 70
Bageghni, S. A., Hemmings, K. E., Zava, N. K., Denton, C. P., Porter, K. E., Ainscough, J., Drinkhill, M. J., & Turner, N. A. (2018) · The FASEB Journal · doi:10.1096/fj.201701455rr · Cited by 70 · cited 1×
“actions of TGF-b on cardiac fibroblasts may involve activation of Smadindependent p38 MAPK, ERK, or Transforming Growth Factor-b-activated kinase (TAK)1 signalling.(114,239,240) However, considering the wide”
BackgroundCXCR4 Antagonism Attenuates the Cardiorenal Consequences of Mineralocorticoid Excess
Chu, P., Zatta, A. J., Kiriazis, H., Chin-Dusting, J. P. F., Du, X., Marshall, T., & Kaye, D. M. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960831 · Cited by 69 · cited 1×
“CXCR4 antagonism reduced cardiac fibrosis in a genetic model of murine cardiomyopathy,(146) and in models of diabetic fibrosis(147) and cardiorenal syndrome.(148) The fibrogenic actions of CXCL12 were attributed to direct pro-migratory effects on fibroblasts, to recruitment of fibroblast progenitors, or to activation…”
BackgroundWnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis
Paik, D. T., Rai, M., Ryzhov, S. V., Sanders, L. H., Aisagbonhi, O. A., Funke, M., Feoktistov, I., & Hatzopoulos, A. K. (2015) · Circulation Research · doi:10.1161/circresaha.115.306886 · Cited by 69 · cited 1×
“It should be emphasized that Wntinduced fibrogenic actions may not be due exclusively to direct fibroblast activation, but may also involve effects on other cell types, including cardiomyocytes, vascular cells, and immune cells.(269,270)”
BackgroundMiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN
Yuan, X., Pan, J., Wen, L., Gong, B., Li, J., Gao, H., Tan, W., Liang, S., Zhang, H., & Wang, X. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00249 · Cited by 68
Meyer, I. S., Jungmann, A., Dieterich, C., Zhang, M., Lasitschka, F., Werkmeister, S., Haas, J., Müller, O. J., Boutros, M., Nahrendorf, M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707565 · Cited by 67 · cited 1×
“It should be emphasized that Wntinduced fibrogenic actions may not be due exclusively to direct fibroblast activation, but may also involve effects on other cell types, including cardiomyocytes, vascular cells, and immune cells.(269,270)”
BackgroundTravers, J. G., Kamal, F., Valiente-Alandí, Í., Nieman, M. L., Sargent, M. A., Lorenz, J. N., Molkentin, J. D., & Blaxall, B. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.049 · Cited by 67 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialÁlvarez, D., Briassouli, P., Clancy, R. M., Zavadil, J., Reed, J. H., Abellar, R. G., Halushka, M. K., Fox-Talbot, K., Barrat, F. J., & Buyon, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263657 · Cited by 66
BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction
Sanders, L. H., Schoenhard, J. A., Saleh, M. A., Mukherjee, A., Ryzhov, S. V., McMaster, W. G., Nolan, K., Gumina, R. J., Thompson, T. B., Magnuson, M. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308700 · Cited by 66
Molecular Imaging for Efficacy of Pharmacologic Intervention in Myocardial Remodeling
van den Borne, S. W. M., Isobe, S., Zandbergen, H. R., Li, P., Petrov, A. D., Wong, N. D., Fujimoto, S., Fujimoto, A., Løvhaug, D., Smits, J. F. M., et al. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.11.011 · Cited by 65
Petrov, V. V., Fagard, R. H., & Lijnen, P. J. (2000) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2000.064 · Cited by 65 · cited 1×
“Some studies have reported that TGF-b stimulates proliferation of cardiac fibroblasts,(235) whereas other investigations demonstrated anti-proliferative effects.(231,236) The contrasting findings likely reflect differences in the state of differentiation of fibroblast populations,(237) the presence or absence of other…”
Gulati, A., Japp, A. G., Raza, S., Halliday, B. P., Jones, D. A., Newsome, S., Ismail, N. A., Morarji, K., Khwaja, J., Spath, N. B., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.118.007722 · Cited by 65
Li, C., Sun, X., Zeng, M., Zheng, X., Zhang, Y., Wan, Q., Zhang, W., Shi, C., Du, L., Ai, T.-J., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09070 · Cited by 64
Nuamnaichati, N., Sato, V. H., Moongkarndi, P., Parichatikanond, W., & Mangmool, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.034 · Cited by 64
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1167 · Cited by 64
Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy
Tan, X., Hu, L., Shu, Z., Chen, L., Li, X., Du, M., Sun, D., Mao, X., Deng, S., Huang, K., et al. (2019) · Diabetes · doi:10.2337/db18-1231 · Cited by 64
Chute, M., Aujla, P. K., Jana, S., & Kassiri, Z. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6040035 · Cited by 64
Bella, G. D., Siciliano, V., Aquaro, G. D., Molinaro, S., Lombardi, M., Carerj, S., Landi, P., Rovai, D., & Pingitore, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs037 · Cited by 63
Qu, X., Liu, Y., Cao, D., Chen, J., Liu, Z., Ji, H., Chen, Y., Zhang, W., Zhu, P., Xiao, D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010943 · Cited by 63 · cited 1×
“suggested that BMP10 may exert anti-fibrotic actions in the isoproterenol-treated heart.(248) Whether these effects involve direct”
BackgroundSomanna, N. K., Manjunath, Y., Garagliano, J. M., Siebenlist, U. K., Mummidi, S., Valente, A. J., & Chandrasekar, B. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.001 · Cited by 62
Strand, M. E., Aronsen, J. M., Braathen, B., Sjaastad, I., Kvaløy, H., Tønnessen, T., Christensen, G., & Lunde, I. G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.003 · Cited by 62
Ohtsu, H., Frank, G. D., Utsunomiya, H., & Eguchi, S. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1315 · Cited by 62
Stawowy, P., Margeta, C., Blaschke, F., Lindschau, C., Spencer-Hänsch, C., Leitges, M., Biagini, G., Fleck, E., & Graf, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.03.002 · Cited by 62
Skrbic, B., Engebretsen, K. V. T., Strand, M. E., Lunde, I. G., Herum, K. M., Marstein, H. S., Sjaastad, I., Lunde, P., Carlson, C. R., Christensen, G., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv041 · Cited by 62
Ekström, K., Lehtonen, J. Y. A., Kandolin, R. M., Räisänen-Sokolowski, A. K., Salmenkivi, K., & Kupari, M. M. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004559 · Cited by 62
LncRNA PCFL promotes cardiac fibrosis via miR-378/GRB2 pathway following myocardial infarction
Sun, F., Zhuang, Y., Zhu, H., Wu, H., Li, D., Zhan, L., Yang, W., Yuan, Y., Xie, Y., Yang, S., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.011 · Cited by 62
Carlson, S., Helterline, D., Asbe, L., Dupras, S. K., Minami, E., Farris, S. D., & Stempien‐Otero, A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.016 · Cited by 61
Persistent Diastolic Dysfunction Late After Valve Replacement in Severe Aortic Regurgitation
Villari, B., Sossalla, S. T., Ciampi, Q., Petruzziello, B., Turina, J., Schneider, J., Turina, M. I., & Hess, O. M. (2009) · Circulation · doi:10.1161/circulationaha.108.812685 · Cited by 60
Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium
Toba, H., Brás, L. E. D. C., Baicu, C. F., Zile, M. R., Lindsey, M. L., & Bradshaw, A. D. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00040.2016 · Cited by 60
BRD4 inhibition for the treatment of pathological organ fibrosis
Stratton, M. S., Haldar, S. M., & McKinsey, T. A. (2017) · F1000Research · doi:10.12688/f1000research.11339.1 · Cited by 60
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway
Yousefi, K., Irion, C. I., Takeuchi, L. M., Ding, W., Lambert, G., Eisenberg, T., Sukkar, S., Granzier, H. L. M., Methawasin, M., Lee, D. I., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.074 · Cited by 60
Tseng, C. C. S., Huibers, M. M. H., van Kuik, J., de Weger, R. A., Vink, A., & de Jonge, N. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9775-8 · Cited by 59 · cited 1×
“human patients with end-stage heart failure, IL-33 and ST2 upregulation were associated with fibrotic changes.(176) In the pressureoverloaded myocardium, IL-33 was found to exert cardioprotective and anti-fibrotic actions, attributed to its binding to the ST2 receptor in cardiomyocytes and fibroblasts.”
BackgroundJunttila, J. M., Holmström, L. T. A., Pylkäs, K., Mantere, T., Kaikkonen, K., Porvari, K., Kortelainen, M.-L., Pakanen, L., Kerkelä, R., Myerburg, R. J., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032175 · Cited by 59
p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts
Sinfield, J. K., Das, A., O'Regan, D. J., Ball, S. G., Porter, K. E., & Turner, N. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.071 · Cited by 58
Trial, J., Entman, M. L., & Cieslik, K. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.017 · Cited by 58
Zhao, R., Ackers-Johnson, M. A., Stenzig, J., Chen, C., Ding, T., Zhou, Y., Wang, P., Ng, S. L., Li, P. Y., Teo, G., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030353 · Cited by 58
Shen, J., Morgan, J., Tesch, G. H., Fuller, P. J., & Young, M. J. (2014) · Endocrinology · doi:10.1210/en.2013-1772 · Cited by 57
Ieronimakis, N. M., Hays, A. L., Janebodin, K., Mahoney, W. M., Duffield, J. S., Majesky, M. W., & Reyes, M. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.014 · Cited by 57 · cited 1×
“changes are prominent in hypertensive heart disease and may reflect fibroblast conversion or fibrogenic activation of vascular endothelial or mural cells,(22,23) or stimulation of adventitial fibroblasts.(24) Whether peri-”
BackgroundEhanire, T. E., Ren, L., Bond, J. E., Medina, M., Li, G. Q., Bashirov, L., Chen, L., Kokosis, G., Ibrahim, M. M., Selim, A. M., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1211-9 · Cited by 57
Rosker, C., Salvarani, N., Schmutz, S., Grand, T., & Rohr, S. (2011) · Circulation Research · doi:10.1161/circresaha.111.244798 · Cited by 57
Beetz, N., Rommel, C., Schnick, T., Neumann, E., Lother, A., Ordonez, E. B. M., Zeeb, M., Preißl, S., Gilsbach, R., Melchior‐Becker, A., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.10.011 · Cited by 57
Abbadi, D., Laroumanie, F., Bizou, M., Pozzo, J., Daviaud, D., Delage, C., Calise, D., Gaits‐Iacovoni, F., Dutaur, M., Tortosa, F., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx221 · Cited by 57
Singh, A., Musa, T. A., Treibel, T. A., Vassiliou, V. S., Captur, G., Chin, C., Dobson, L. E., Pica, S., Loudon, M. A., Malley, T. S., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-314987 · Cited by 57
Ermolova, N. V., Martinez, L., Vetrone, S. A., Jordan, M. C., Roos, K. P., Sweeney, H. L., & Spencer, M. J. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.04.006 · Cited by 56
Grosche, J., Meißner, J., & Eble, J. A. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.03.005 · Cited by 56
Mukherjee, S., Ayaub, E. A., Murphy, J. S., Lü, C., Kolb, M. R. J., Ask, K., & Janssen, L. J. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0009oc · Cited by 55
PDGF-A, -C, and -D but not PDGF-B Increase TGF-β1 and Chronic Rejection in Rat Cardiac Allografts
Tuuminen, R., Nykänen, A. I., Krebs, R., Soronen, J., Pajusola, K., Keränen, M. A. I., Koskinen, P., Alitalo, K. K., & Lemström, K. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178558 · Cited by 55
CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis
Chu, P., Walder, K. R., Horlock, D., Williams, D., Nelson, E., BYRNE, M. J., Jandeleit-Dahm, K. A. M., Zimmet, P., & Kaye, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133616 · Cited by 54
Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB
Tian, B., Liu, J., Bitterman, P. B., & Bache, R. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01139.2002 · Cited by 54
Focal Adhesion Kinase: A Key Mediator of Transforming Growth Factor Beta Signaling in Fibroblasts
Leask, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0363 · Cited by 54
Ye, H., Ling, S., Castillo, A. C., Thomas, B., Long, B., Qian, J., Perez-Polo, J. R., Ye, Y., Chen, X., & Birnbaum, Y. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00892 · Cited by 54
Merino, D., Villar, A. V., García, R., Tramullas, M., Ruiz‐Guerrero, L., Ribas, C., Cabezudo, S., Nistal, J. F., & Hurlé, M. A. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw076 · Cited by 53 · cited 1×
“collagen deposition in models of pressure overload and diabetic cardiomyopathy.(22,245,246) The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.”
BackgroundRoell, W., Klein, A. M., Breitbach, M., Becker, T., Parikh, A., Lee, J., Zimmermann, K., Reining, S., Gabris, B., Ottersbach, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25147-8 · Cited by 53
Meng, Q., Bhandary, B., Bhuiyan, M. S., James, J., Osińska, H. E., Valiente-Alandí, Í., Shay‐Winkler, K., Gulick, J. M., Molkentin, J. D., Blaxall, B. C., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313089 · Cited by 53
FAK regulates cardiomyocyte survival following ischemia/reperfusion
Hakim, Z. S., DiMichele, L. A., Rojas, M., Meredith, D., Mack, C. P., & Taylor, J. M. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.017 · Cited by 52
Podesser, B. K., Kreibich, M., Dzilic, E., Santer, D., Förster, L., Trojanek, S., Abraham, D., Krššák, M., Klein, K. U., Tretter, V. E., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001628 · Cited by 52
Syndecan‐4 Protects the Heart From the Profibrotic Effects of Thrombin‐Cleaved Osteopontin
Herum, K. M., Romaine, A., Wang, A., Melleby, A. O., Strand, M. E., Pacheco, J., Braathen, B., Dunér, P., Tønnessen, T., Lunde, I. G., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013518 · Cited by 52
Fan, G., Wang, W., Zhao, H., Cai, L., Zhang, P., Yang, Z., Zhang, J., & Wang, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430373 · Cited by 51
Effects of interleukin-33 on cardiac fibroblast gene expression and activity
Zhu, J., & Carver, W. E. (2012) · Cytokine · doi:10.1016/j.cyto.2012.02.008 · Cited by 51 · cited 1×
“synthesis by cardiac fibroblasts, but inhibited their migratory capacity and enhanced expression of inflammatory genes.(178) Cardiac fibrosis 1457”
BackgroundMarijianowski, M. M. H., Teeling, P., & Becker, A. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00100-9 · Cited by 51
New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process
Gil‐Cayuela, C., Roselló‐Lletí, E., Ortega, A., Tarazón, E., Triviño, J. C., Martínez‐Dolz, L., González‐Juanatey, J. R., Lago, F., Portolés, M., & Rivera, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168130 · Cited by 51
Zhang, Y., Geng, C., Yang, J., Fang, J., Yan, X., Li, P., Zou, L., Chen, C., Guo, S., Li, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165551 · Cited by 51
Non-coding RNAs as modulators of the cardiac fibroblast phenotype
Piccoli, M.-T., Bär, C., & Thum, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.023 · Cited by 50
Myocardial Fibrosis Predicts 10-Year Survival in Patients Undergoing Aortic Valve Replacement
Herrmann, S., Fries, B., Salinger, T., Liu, D., Hu, K., Gensler, D., Strotmann, J. M., Christa, M., Beer, M., Gattenlöhner, S., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007131 · Cited by 50
Huang, S., Chen, B., Humeres, C. D., Alex, L., Hanna, A., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118703 · Cited by 50
Self-citationKanagala, P., Arnold, J. R., Singh, A., Chan, D. C. S., Cheng, A. S. H., Khan, J. N., Gulsin, G. S., Yang, J., Zhao, L., Gupta, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232280 · Cited by 50
Garg, P., Broadbent, D. A., Swoboda, P., Foley, J. R., Fent, G. J., Musa, T. A., Ripley, D. P., Erhayiem, B., Dobson, L. E., McDiarmid, A. K., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0384-0 · Cited by 49
Changes in cardiac resident fibroblast physiology and phenotype in aging
Trial, J., & Cieslik, K. A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2018 · Cited by 49
Shimizu, K., Sunagawa, Y., Funamoto, M., Wakabayashi, H., Genpei, M., Miyazaki, Y., Katanasaka, Y., Sari, N., Shimizu, S., Katayama, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64207-w · Cited by 49
Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling
Shinde, A. V., Dobaczewski, M. P., de Haan, J. J., Saxena, A., Lee, K.-K., Xia, Y., Chen, W., Su, Y., Hanif, W., Madahar, I., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx053 · Cited by 48
Self-citationCell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure
Farris, S. D., Don, C. W., Helterline, D., Costa, C. R., Plummer, T., Steffes, S. S., Mahr, C., Mokadam, N. A., & Stempien‐Otero, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.040 · Cited by 48
FAK, PIP5KIγ and gelsolin cooperatively mediate force-induced expression of α-smooth muscle actin
Chan, M. W. C., Arora, P. D., Bozavikov, P., & McCulloch, C. A. (2009) · Journal of Cell Science · doi:10.1242/jcs.044008 · Cited by 47
Zibadi, S., Vazquez, R., Moore, D., Larson, D. F., & WATSON, R. R. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00398.2009 · Cited by 47
Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy
Mueller, E. E., Momen, A., Massé, S., Zhou, Y., Liu, J., Backx, P. H., Henkelman, R. M., Nanthakumar, K., Stewart, D. J., & Husain, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq351 · Cited by 47 · cited 1×
“Cardiac ET-1 overexpression in mice induced myocardial fibrosis associated with both systolic and diastolic dysfunction.(278) Moreover, endothelial-specific loss of ET-1 attenuated fibrosis in a model of angiotensin II infusion.”
BackgroundOkada, M., Oba, Y., & Yamawaki, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.019 · Cited by 46
Follistatin-Like 3 Mediates Paracrine Fibroblast Activation by Cardiomyocytes
Panse, K. D., Felkin, L. E., López-Olañeta, M. M., Gómez-Salinero, J. M., Villalba‐Orero, M., Muñoz, L., Nakamura, K., Shimano, M., Walsh, K. X., Barton, P. J. R., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9400-9 · Cited by 46
Echtermeyer, F. G., Harendza, T., Hubrich, S., Lorenz, A., Herzog, C., Mueller, M., Schmitz, M., Grund, A., Larmann, J., Stypmann, J., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr149 · Cited by 46
van Nieuwenhoven, F. A., Hemmings, K. E., Porter, K. E., & Turner, N. A. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.03.008 · Cited by 45
Platelet-derived growth factor blockade on cardiac remodeling following infarction
Liu, C., Zhao, W., Meng, W., Zhao, T., Chen, Y., Ahokas, R. A., Liu, H., & Sun, Y. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2197-x · Cited by 45
Tao, H., Song, Z., Ding, X., Yang, J., Shi, K., & Li, J. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9694-z · Cited by 45
Leukocyte-Dependent Regulation of Cardiac Fibrosis
Okyere, A. D., & Tilley, D. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00301 · Cited by 45
Kimura, Y., Izumiya, Y., Hanatani, S., Yamamoto, E., Kusaka, H., Tokitsu, T., Takashio, S., Sakamoto, K., Tsujita, K., Tanaka, T., et al. (2014) · Heart and Vessels · doi:10.1007/s00380-014-0571-y · Cited by 44
Nguyen, M., Kiriazis, H., Ruggiero, D., Gao, X., Su, Y., Jian, A., Han, L., McMullen, J. R., & Du, X. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00405.2015 · Cited by 44
Endothelial dysfunction is a superinducer of syndecan-4: fibrogenic role of its ectodomain
Lipphardt, M., Song, J. W., Ratliff, B. B., Dihazi, H., Muller, G. A., & Goligorsky, M. S. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00548.2017 · Cited by 44
Jing, R., Long, T.-Y., Pan, W., Li, F., & Qy, X. (2019) · PubMed · doi:10.26355/eurrev_201907_18450 · Cited by 44
IL-1β suppresses TGF-β-mediated myofibroblast differentiation in cardiac fibroblasts
Brønnum, H., Eskildsen, T. V., Andersen, D. C., Schneider, M., & Sheikh, S. P. (2013) · Growth Factors · doi:10.3109/08977194.2013.787994 · Cited by 43
Nattel, S. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw092 · Cited by 43
Long Noncoding RNA: a New Contributor and Potential Therapeutic Target in Fibrosis
Jiang, X., & Zhang, F. (2017) · Epigenomics · doi:10.2217/epi-2017-0020 · Cited by 43
Flinn, M. A., Jeffery, B. E., O'Meara, C. C., & Link, B. A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy243 · Cited by 42
Vanhoutte, D., van Almen, G. C., Aelst, L. N. L. V., Cleemput, J. V., Droogné, W., Jin, Y., de Werf, F. V., Carmeliet, P., Vanhaecke, J., Papageorgiou, A., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs375 · Cited by 40 · cited 1×
“mRNA levels were associated with collagen deposition and gelatinase expression,(151) and in transplanted human hearts myocardial IL-6 levels were associated with fibrotic remodelling.(152) These associations suggest”
BackgroundShinde, A. V., Su, Y., Palanski, B. A., Fujikura, K., Garcia, M. J., & Frangogiannis, N. G. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.016 · Cited by 40
Self-citationTrembley, M. A., Quijada, P. J., Agulló-Pascual, E., Tylock, K. M., Colpan, M., Dirkx, R. A., Myers, J. R., Mickelsen, D. M., Bentley, K. L. D. M., Rothenberg, E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031788 · Cited by 40
Le, D. E., Pascotto, M., Leong-Poi, H. M., Sarı, İ., Micari, A., & Kaul, S. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0384-7 · Cited by 39
Zhang, P., Wang, W., Wang, X., Wang, X., Song, Y., Zhang, J., & Zhao, H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.113 · Cited by 38
Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure
Verjans, R., Derks, W. J. A., Korn, K., Sönnichsen, B., van Leeuwen, R. E. W., Schroen, B. L. M., van Bilsen, M., & Heymans, S. R. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-41491-9 · Cited by 38
Colombo, F., Noël, J., Mayers, P., Mercier, I., & Calderone, A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1381 · Cited by 37
Lumican -null mice are susceptible to aging and isoproterenol-induced myocardial fibrosis
Chen, S., Tung, Y., Jung, S., Chu, Y., Lin, P.-J., Kao, W. W. ‐., & Chu, P. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.033 · Cited by 37
Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis
Trial, J., Heredia, C. P., Taffet, G. E., Entman, M. L., & Cieslik, K. A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0623-4 · Cited by 37
Midgley, A. C., Oltean, S., Hascall, V., Woods, E. L., Steadman, R., Phillips, A. O., & Meran, S. (2017) · Science Signaling · doi:10.1126/scisignal.aao1822 · Cited by 37
Pericytes in the infarcted heart
Alex, L., & Frangogiannis, N. G. (2019) · Vascular Biology · doi:10.1530/vb-19-0007 · Cited by 37 · cited 1×
“Neutralization of PDGFR-b signalilng in infarcted mice reduced collagen deposition, but had much more impressive effects in perturbation of vascular maturation, highlighting the significance of PDGFRb actions on vascular mural cells.(256,261) 5.”
BackgroundSelf-citationWang, H., Leinwand, L. A., & Anseth, K. S. (2014) · The FASEB Journal · doi:10.1096/fj.14-254623 · Cited by 36 · cited 1×
“actions of TGF-b on cardiac fibroblasts may involve activation of Smadindependent p38 MAPK, ERK, or Transforming Growth Factor-b-activated kinase (TAK)1 signalling.(114,239,240) However, considering the wide”
BackgroundArrhythmogenic Right Ventricular Cardiomyopathy
Hamilton, R. M. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02384.x · Cited by 36
Huguier, V., Giot, J., Simonneau, M., Levillain, P., Charreau, S., Garcia, M., Jégou, J., Bodet, C., Morel, F., Lecron, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38572-0 · Cited by 36
Caballero, E. P., Santamaría, M. H., & Corral, R. S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.006 · Cited by 35
Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis
Leipner, C., Grün, K., Müller, A., Buchdunger, E., Borsi, L., Kosmehl, H., Berndt, A., Janik, T., Uecker, A., Kiehntopf, M., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn063 · Cited by 34 · cited 1×
“administration of the non-specific small molecule kinase inhibitor imatinib was found to reduce interstitial fibrosis in models of MI(258) and viral myocarditis.(259)”
BackgroundCan Myocardial Fibrosis Be Reversed?
Frangogiannis, N. G. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.094 · Cited by 34 · cited 1×
“On the other hand, higher levels of ECM cross-linking and a hypocellular interstitium may mark fibrotic lesions with low potential reversibility.(29)”
BackgroundSelf-citationQuijada, P. J., Misra, A., Velasquez, L. S., Burke, R. M., Lighthouse, J. K., Mickelsen, D. M., Dirkx, R. A., & Small, E. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.015 · Cited by 33
Mitogenic effect of PDGF-AA on cardiac fibroblasts
Simm, A., Nestler, M., & Hoppe, V. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050209 · Cited by 32 · cited 1×
“In vitro, PDGF-A and PDGFD potently stimulate cardiac fibroblast proliferation and ECM protein synthesis.(252,253) In vivo, overexpression of PDGF-A or PDGF-D cause marked fibrotic cardiomyopathy associated with fibroblast activation.”
BackgroundTranscardiac extraction of circulating endothelin-1 across the failing heart
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01006-7 · Cited by 32
Hajj, E. C. E., Hajj, M. C. E., Ninh, V. K., & Gardner, J. D. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215616511 · Cited by 31
Schuetze, K. B., Stratton, M. S., Blakeslee, W. W., Wempe, M. F., Wagner, F. F., Holson, E. B., Kuo, Y., Andrews, A. J., Gilbert, T. M., Hooker, J. M., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237701 · Cited by 31
CD44 Deficiency in Mice Protects the Heart Against Angiotensin Ii-Induced Cardiac Fibrosis
Yang, L., Qin, D., James, E. A., McKallip, R. J., Wang, N.-P., Zhang, W., Zheng, R., Han, Q., & Zhao, Z. (2018) · Shock · doi:10.1097/shk.0000000000001132 · Cited by 28
Saraswati, S., Lietman, C., Li, B., Mathew, S., Zent, R., & Young, P. P. (2020) · The FASEB Journal · doi:10.1096/fj.201902815r · Cited by 28
Seitz, J., Horvilleur, J., Lacotte, J., h-Icí, D. O., Mouhoub, Y., Maltret, A., Salerno, F., Mylotte, D., Monchi, M., & Garot, J. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03148.x · Cited by 27
Perea, R. J., Morales‐Ruiz, M., Ortiz-Pérez, J. T., Bosch, X., Andreu, D., Borràs, R., Acosta, J., Penela, D., Prat, S., de Caralt, T. M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.070 · Cited by 27
Tissue transglutaminase in the pathogenesis of heart failure
Shinde, A. V., & Frangogiannis, N. G. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0028-9 · Cited by 27
Self-citationAlterations in Cardiac Structure and Function in a Murine Model of Chronic Alcohol Consumption
Law, B. A., Levick, S. P., & Carver, W. E. (2012) · Microscopy and Microanalysis · doi:10.1017/s1431927612000372 · Cited by 26 · cited 1×
“Infiltration of the heart with activated myofibroblasts has been reported in a wide range of pathologic conditions, including MI,(30,38) non-infarctive ischaemic cardiomyopathy,(27,39) myocarditis,(40) diseases associated with cardiac pressure or volume overload,(41,42) and alcoholic cardiomyopathy.(43) However, myofi…”
BackgroundNguyen, M., Su, Y., Kiriazis, H., Yang, Y., Gao, X., McMullen, J. R., Dart, A. M., & Du, X. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00337.2017 · Cited by 26
The Cellular Origin of Activated Fibroblasts in the Infarcted and Remodeling Myocardium
Alex, L., & Frangogiannis, N. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312654 · Cited by 26 · cited 1×
“haematopoietic cells the role of circulating fibroblast progenitors in cardiac fibrosis remains controversial.(141)”
BackgroundSelf-citationGulsin, G. S., Kanagala, P., Chan, D. C. S., Cheng, A. S. H., Athithan, L., Graham-Brown, M. P. M., Singh, A., Yang, J., Li, Z., Khunti, K., et al. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819861593 · Cited by 26
Regan, C. P., Anderson, P. G., Bishop, S. P., & Berecek, K. H. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.5.h2131 · Cited by 25 · cited 1×
“AT1 inhibition attenuated interstitial fibrosis in models of MI(93) and left ventricular pressure overload.(94)”
Methoddel Villar, C. P., Savvatis, K., López, B., Kašner, M., Martínez‐Legazpi, P., Yotti, R., González, A., Díez, J., Fernández‐Avilés, F., Tschöpe, C., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx047 · Cited by 25
Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice
Imaeda, A., Tanaka, S., Tonegawa, K., Fuchigami, S., Obana, M., Maeda, M., Kihara, M., Kiyonari, H., Conway, S. J., Fujio, Y., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.070 · Cited by 25 · cited 1×
“Moreover, b2-AR signalling in myofibroblasts has been reported to exert pro-hypertrophic actions through paracrine mechanisms.(118) Although the role of b3-AR signalling in fibroblasts is unknown,”
BackgroundDeficiency of MicroRNA miR‐1954 Promotes Cardiac Remodeling and Fibrosis
Chiasson, V. L., Takano, A. P. C., Guleria, R. S., & Gupta, S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012880 · Cited by 25
p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts
Ongherth, A., Pasch, S., Wuertz, C. M., Nowak, K., Kittana, N., Weis, C. A., Jatho, A., Vettel, C., Tiburcy, M., Toischer, K., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.09.009 · Cited by 24
Gibbs, T., Villa, A. D. M., Sammut, E. C., Jeyabraba, S., Carr‐White, G., Ismail, T. F., Mullen, G. E. D., Ganeshan, B., & Chiribiri, A. (2018) · Clinical Radiology · doi:10.1016/j.crad.2018.08.012 · Cited by 24
Farivar, R. S., Crawford, D. C., Chobanian, A. V., & Brecher, P. I. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.809 · Cited by 22
AT1Receptor Gene Regulation in Cardiac Myocytes and Fibroblasts
Everett, A. D. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0162 · Cited by 22
Focal Adhesion Kinase Regulates Smooth Muscle Cell Recruitment to the Developing Vasculature
Cheng, Z., Sundberg-Smith, L. J., Mangiante, L., Sayers, R. L., Hakim, Z. S., Musunuri, S., Maguire, C. T., Majesky, M. W., Zhou, Z., Mack, C. P., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232231 · Cited by 21
Okada, M., Murata, N., & Yamawaki, H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00329.2015 · Cited by 21
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
Chu, P., Joshi, M. S., Horlock, D., Kiriazis, H., & Kaye, D. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00117 · Cited by 21
Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure
Gardner, G., Travers, J. G., Qian, J., Liu, G., Haghighi, K., Robbins, N., Jiang, M., Li, Y., Fan, G., Rubinstein, J., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.11.007 · Cited by 21
Cited by
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
“Cardiac fibroblast can sense mechanical cues through mechanosensitive receptors, and channels, hence promoting intracellular fibrogenic signaling.(634) Previous studies demonstrated that cyclic stretch promotes fibroblast activation and FMT.”
BackgroundMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044004 · Cited by 366
“Cardiac fibrosis is an aberrant thickening of the heart valves caused by unsuitable fibroblast proliferation, but it is more frequently used to describe the excessive deposition of ECM in the cardiac muscle, as described in Figure 12 [123].”
BackgroundGoette, A., Corradi, D., Dobrev, D., Aguinaga, L., Cabrera, J.-A., Chugh, S. S., de Groot, J. R., Soulat-Dufour, L., Fenelon, G., Hatem, S. N., et al. (2024) · Europace · doi:10.1093/europace/euae204 · Cited by 310
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Metadata
- Authors
- Frangogiannis, N. G.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Frangogiannis, Nikolaos G
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 117
- Issue
- 6
- Pages
- 1450-1488
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC8152700
- OpenAlex
- W4210607007
- Cited by
- 1,229
- References
- 615
- Citations by year
- 2026: 265 · 2025: 319 · 2024: 273 · 2023: 210 · 2022: 130 · 2021: 32
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 HL76246, R01 HL85440, R01 HL149407)
- U.S. Department of Defense (PR151134, PR151029, PR181464)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- myocardial fibrosis, myocardial fibroblasts, myofibroblasts, extracellular matrix deposition, TGF-beta, platelet-derived growth factor, cytokines, mechanoreceptors, integrins, pressure overload, myocardial infarction, heart failure, familial cardiomyopathy, diabetic cardiomyopathy, cardiac arrhythmias
- MeSH terms
- Antifibrotic Agents, Animals, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Cardiomyopathies, Myocytes, Cardiac, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.